Skip to content
MDTMedtronic plc

What Is MDT Fair Value?

Medtronic plc (MDT) fair value estimate using multiple valuation models, updated daily.

As of August 1, 2026, Medtronic plc (MDT) has a composite fair value estimate of $83.71 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $85.39, suggesting the stock is fair value by 2.0%.

Data as of August 1, 2026 (today)

Composite Fair Value

Fair Value4 of 4 models

$83.71

vs. current price of $85.39(-2.0%)

Undervalued$83.71Overvalued
$85.39

How Is MDT Fair Value Calculated?

Four independent models estimate what MDT is worth. Each uses different inputs and assumptions. The composite blends them by weight.

MDT Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$95.32

+11.6%

Fair Value

Inputs used

FCF: 4.6BGrowth: 7.7%Discount: 7%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$77.40

-9.4%

Fair Value

Inputs used

Dividend: $2.88/yrReq. Return: 8%Growth: 3.8%

MDT Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$71.91

-15.8%

Overvalued

Inputs used

EPS: $5.95Book Value: $38.64

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$59.49

-30.3%

Overvalued

Inputs used

EPS: $5.95Growth: 7.7%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$95.32Fair Value

Current price $85.39 is 11.6% below this estimate

CheapFair ValueExpensive
7.7%
0.0%30.0%
6.9%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$4.98B$4.66B
Year 2$5.36B$4.69B
Year 3$5.78B$4.73B
Year 4$6.22B$4.76B
Year 5$6.70B$4.79B
Year 6$7.21B$4.83B
Year 7$7.77B$4.86B
Year 8$8.36B$4.90B
Year 9$9.01B$4.93B
Year 10$9.70B$4.97B
Terminal Value$225.13B$115.35B

What Are MDT's Key Financial Metrics?

Earnings & Growth

Current Price

$85.39

EPS (TTM)

$3.73

Forward P/E

13.3

Profit Margin

13.2%

Cash & Balance Sheet

Free Cash Flow

4.6B

EBITDA

10.1B

Book Value

$38.64

Total Debt

29.1B

What Do Analysts Say About MDT?

Low

$78.00

Average

$98.44

High

$121.00

Upside

+15.3%

Current $85.39Avg Target $98.44Buy25 analysts

MDT Fair Value FAQ

What is the fair value of MDT?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), MDT's estimated fair value is $83.71. The stock is currently trading at $85.39, which makes it fair value by our analysis.

How is MDT's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is MDT overvalued or undervalued?

Based on our analysis, MDT is fair value. The current price of $85.39 is 2.0% above our estimated fair value of $83.71.

What do Wall Street analysts say about MDT?

25 analysts cover Medtronic plc with a consensus rating of "Buy." The average price target is $98.44, ranging from $78.00 to $121.00. This implies 15.3% upside from the current price.